Pharmacy World & Science

, Volume 29, Issue 3, pp 278–339 | Cite as



Lilly UK Critical Care Award 2006

Does computerised, decision-supported intensive insulin therapy achieve tighter glycaemic control than conventional insulin therapy?

R. Shulman1, N. Shah2, P. Glynne3, R. Greene 2

1Department of Pharmacy, Department of Intensive Care, University College Hospital, London, UK; 2Department of Pharmacy, King’s University, London, UK; 3Department of Intensive Care, University College Hospital, London, UK


Hyperglycaemia is associated with increased mortality in critical illness, and is related to excessive gluconeogenesis, relative insulin deficiency, and insulin resistance. Intensive insulin therapy (IIT), aiming for tight glycaemic control (TGC) [blood glucose (BG) 4.4–6.1 mmol/l], has resulted in a significant mortality and morbidity reduction compared to those treated with conventional treatment [1, 2]. The degree to which BG should be controlled is debated. Data from an observational study suggest that a less stringent target BG range of...

Copyright information

© Springer Science+Business Media, LLC 2007

Personalised recommendations